<DOC>
	<DOCNO>NCT03081988</DOCNO>
	<brief_summary>1 . Retrospective review old patient - Analysis prediction factor concomitant chemo-radiotherapy locally advanced advanced esophageal cancer 2005 2015 2 . Prospective case-control study : RNA sequence &amp; miRNA microarray - naive esophageal cancer patient plan receive concomitant chemo-radiotherapy - acquirement tissue , blood , clinical information - isolation RNA , DNA , serum database clinical &amp; demographic information ***Analysis mRNA sequence / miRNA sequencing**** first analysis RNA sequencing : bioinformatician second analysis RNA sequencing : principle investigator 3 . Experimental set qPCR ( esophageal tissue ) study group 4 . TMA screen exon gene 5. validation set qPCR ( esophageal tissue ) 6. follow-up circulate miRNA blood ( baseline blood &amp; post-CCRT blood 3M , 6M , 12M ) 7 . Prediction model CCRT response esophageal Cancer base clinical molecular factor 8 . Validate prediction model .</brief_summary>
	<brief_title>Prediction Model Response CCRT Esophageal Cancer</brief_title>
	<detailed_description>1 . Retrospective review old patient - Analysis prediction factor concomitant chemo-radiotherapy locally advanced advanced esophageal cancer 2005 2015 Study Group 1. non responder 2 . CR recurrence 3 . CR survival loner 2 year 2 . Prospective case-control study : RNA sequence &amp; miRNA microarray : naive esophageal cancer patient plan receive concomitant chemo-radiotherapy - acquirement tissue , blood , clinical information - isolation RNA , DNA , serum database clinical &amp; demographic information study group 1. non-responder ( N=14 ) 2 . Complete Remission ( N=14 ) For consider drop rate , 2-fold screening ***Analysis mRNA sequence / miRNA sequencing**** first analysis RNA sequencing : bioinformatician second analysis RNA sequencing : principle investigator 3 ) Experimental set qPCR ( esophageal tissue ) study group 1. non-responder ( N=40 ) 2. complete remission ( N=40 ) 4 ) TMA screen exon gene 5 ) validation set qPCR ( esophageal tissue ) new esophageal cancer set 1. non-responder ( N=30 ) 2. complete remission ( N=30 ) 6 ) follow-up circulate miRNA blood ( baseline blood &amp; post-CCRT blood 3M , 6M , 12M ) 7 ) Prediction model CCRT response esophageal Cancer base clinical molecular factor Test several combination model 1 ) gene + gene combination , 2 ) gene + clinical information combination , 3 ) gene + gene + clinical information combination 8 ) Validate prediction model .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>1. locally advanced advanced esophageal cancer want concomitant chemoradiotherapy 2. person assign write informed consent . 1. person did't assign inform consent 2. organ cancer 3. heavy alcoholic</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Esophageal Cancer</keyword>
	<keyword>chemoradiotherapy response</keyword>
	<keyword>molecular factor</keyword>
</DOC>